These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 28506100

  • 1. Diagnostic performance of CTLA-4, carcinoembryonic antigen and CYFRA 21-1 for malignant pleural effusion.
    Chen M, Xie S, Wan C, Zeng N, Wu Y, Qin J, Shen Y, Wen F.
    Postgrad Med; 2017 Aug; 129(6):644-648. PubMed ID: 28506100
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Diagnostic Accuracy of Combinations of Tumor Markers for Malignant Pleural Effusion: An Updated Meta-Analysis.
    Yang Y, Liu YL, Shi HZ.
    Respiration; 2017 Aug; 94(1):62-69. PubMed ID: 28427079
    [Abstract] [Full Text] [Related]

  • 5. [The value of B7-H4 and carcinoembryonic antigen in diagnosing the benign and malignant pleural effusion].
    Wei F, Wei Y, Li LF, Li GL, Wang GJ.
    Zhonghua Zhong Liu Za Zhi; 2017 Jul 23; 39(7):524-527. PubMed ID: 28728299
    [Abstract] [Full Text] [Related]

  • 6. Diagnostic value of Her-2/neu, Cyfra 21-1, and carcinoembryonic antigen levels in malignant pleural effusions of lung adenocarcinoma.
    Huang WW, Tsao SM, Lai CL, Su CC, Tseng CE.
    Pathology; 2010 Apr 23; 42(3):224-8. PubMed ID: 20350214
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Evaluation of cytokeratin 19 fragment (CYFRA 21-1) as a tumor marker in malignant pleural effusion.
    Lai RS, Chen CC, Lee PC, Lu JY.
    Jpn J Clin Oncol; 1999 Sep 23; 29(9):421-4. PubMed ID: 10563194
    [Abstract] [Full Text] [Related]

  • 11. Downregulation of cell-free miR-198 as a diagnostic biomarker for lung adenocarcinoma-associated malignant pleural effusion.
    Han HS, Yun J, Lim SN, Han JH, Lee KH, Kim ST, Kang MH, Son SM, Lee YM, Choi SY, Yun SJ, Kim WJ, Lee OJ.
    Int J Cancer; 2013 Aug 01; 133(3):645-52. PubMed ID: 23354517
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic value of soluble receptor-binding cancer antigen expressed on SiSo cells and carcinoembryonic antigen in malignant pleural effusion in patients with lung cancer.
    Xu CH, Hao KK, Yu LK, Zhang XW.
    Asia Pac J Clin Oncol; 2015 Mar 01; 11(1):28-33. PubMed ID: 24720371
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic value of MUC1 and EpCAM mRNA as tumor markers in differentiating benign from malignant pleural effusion.
    Sun W, Li J, Jiang HG, Ge LP, Wang Y.
    QJM; 2014 Dec 01; 107(12):1001-7. PubMed ID: 24939190
    [Abstract] [Full Text] [Related]

  • 14. Is neuron-specific enolase useful for diagnosing malignant pleural effusions? evidence from a validation study and meta-analysis.
    Zhu J, Feng M, Liang L, Zeng N, Wan C, Yang T, Shen Y, Wen F.
    BMC Cancer; 2017 Aug 30; 17(1):590. PubMed ID: 28854885
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Diagnostic accuracy of endostatin for malignant pleural effusion: A clinical study and meta-analysis.
    Tian P, Shen Y, Feng M, Zhu J, Song H, Wan C, Chen L, Wen F.
    Postgrad Med; 2015 Jun 30; 127(5):529-34. PubMed ID: 25979108
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.